2Aiello L P,Cahill M T,Wong J S. Systemic considerations in the management of diabetic retinopathy [J]. Am J Ophthalmol,2001,132(5) : 760-776.
3Ferris F L,Davis M,Aiello L. Treatment of diabetic retinopathy [J]. N Engl J Med,1999,341(9) :667-678.
4Zander E, Herfurth S, Bohl B, et al. Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors[J]. Br J Ophthalmol, 2000,84 (8) : 871-876.
5Davis M D,Fisher M R,Gangnon R E, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report # 18[J]. Invest Ophthalmol Vis Sci,1998,39(2):233-252.
6Aiello L M. Preserving human vision: eliminating blindness from diabetes mellitus[J]. J Am Optom Assoc, 1998,69 ( 11 ) :690-692.
7Hubbard LD,Brothers RJ,King WN,et al.Methods forevaluation of retinal microvascular abnormalities associated withhypertension/ sclerosis in the atherosclerosis risk in communitiesstudy[J].Oph- thalmology,1999,106:2269-2280.
